Dampak Kelebihan Kapasitas Terhadap Pemenuhan Hak-Hak Warga Binaan Di Lembaga Pemasyarakatan Kelas IIA Jember

Overcapacity of detainees occurs in almost all prisons, this excess capacity causes various problems in prisons, such as the failure of the main purpose of the prison, namely the development of Correctional Assisted Citizens (WBP) and can lead to new crimes due to the excess capacity. The excess capacity of the inmates will have an impact on the fulfillment of the rights that should be obtained by the inmates. The aim of this research is to find out the impact of excess capacity of inmates on the fulfillment of the rights of inmates in the Class IIA Jember Penitentiary. This research uses normative and empirical research methods. The results showed that the impact of the excess capacity of inmates in the Class IIA Jember Penitentiary, among others: the difficulty of the prisoners to rest and activities, disruption of the rights of inmates, inadequate sanitation, conflicts that cause fights, and less than optimal supervision by officers. In an effort to overcome the impact of excess capacity of WBP, Jember Prison carries out various preventive and repressive efforts

Tribonema viride (Xanthophyta) on cultivated grassland during winter and spring

ABSTRACT: A yellow-green alga, Tribonema viride Pascher, has been detected on several grass fields in N-Iceland after the meltwater runoff. When the fields dry out, the filaments are left white and bleached, entangled with the grass leaves. Four species of saprophytic fungi are reported, isolated from the samples of the alga

New Business Innovation Ideas are going to Change West to Eastern Countries (China): A Case Study on a Chinese Watch Company

Many European companies are keen to come to China. While in the past, European companies came to China to take advantage of low-cost manufacturing for export, more recently, they have come to enter the Chinese domestic market, establish R&D, engage in cooperative development, take advantage of a skilled work force, establish suppliers, and develop long-term partnerships in China. In order to achieve this, they are often willing to ‘transfer’ their key technology and designs to Chinese subsidiaries of European firms, joint-venture (JV) partners, or Chinese manufacturing and service companies. One of the challenges facing European companies coming to China is devising creative solutions to minimize the risk to their intellectual property (IP) associated with such technology transfers. Keywords: Skagen, design, cost, China, Europe, pestel, economics, innovation.

Gibbs energies of reaction and microbial mutualism in anaerobic deep subseafloor sediments of ODP Site 1226

In situ Gibbs energies of reaction (AG) for acetate-oxidizing sulfate reduction, acetate-oxidizing iron reduction, and acetoclastic methanogenesis, and sulfate-reducing methanotrophy are consistently negative and relatively constant throughout most of the sediment column at the eastern equatorial Pacific Ocean Drilling Program (ODP) Site 1226. The energy yields (-Delta G) closely match the values (for acetate-oxidizing sulfate reduction and acetoclastic methanogenesis) in published culturing experiments with actively growing cells and, for sulfate-reducing methanotrophy, in other environments. Although microbes mediating these reactions compete for substrates, mutualistic interactions between them appear to sustain their co-existence in deep subseafloor sediments for millions of years (the interval over which the sediments have been deposited). These competing and mutualistic interactions collectively constitute a highly coupled reaction network where relative rates of reaction are regulated by the in situ Gibbs energies of reaction. (C) 2010 Elsevier Ltd. All rights reserved.NASA Astrobiology Institut

THE DIAGNOSIS AND TREATMENT OF PERIPHERAL LYMPHEDEMA: 2013 CONSENSUS DOCUMENT OF THE INTERNATIONAL SOCIETY OF LYMPHOLOGY

This International Society of Lymphology(ISL) Consensus Document is the currentrevision of the 1995 Document for theevaluation and management of peripherallymphedema (1) for discussion at the XXIVInternational Congress of Lymphology. It isbased upon modifications: [A] suggested andpublished following the 1997 XVI InternationalCongress of Lymphology (ICL) inMadrid, Spain (2) discussed at the 1999 XVIIICL in Chennai, India (3) and considered/confirmed at the 2000 (ISL) ExecutiveCommittee meeting in Hinterzarten, Germany(4); [B] derived from integration ofdiscussions and written comments obtainedduring and following the 2001 XVIII ICL inGenoa, Italy as modified at the 2003 ISLExecutive Committee meeting in Cordoba,Argentina (5); [C] suggested from comments,criticisms, and rebuttals as published in theDecember 2004 issue of Lymphology (6);[D] discussed in both the 2005 XX ICL inSalvador, Brazil and the 2007 XXI ICL inShanghai, China and modified at the 2008Executive Committee Meeting in Naples, Italy(7,8); and [E] modified from discussions andwritten comments from the 2009 XXII ICLin Sydney, Australia, the 2011 XXIII ICL inMalmo, Sweden and 2012 ExecutiveCommittee Meetings.The document attempts to amalgamatethe broad spectrum of protocols advocatedworldwide for the diagnosis and treatment ofperipheral lymphedema into a coordinatedproclamation representing a “Consensus” ofthe international community. The document is not meant to override individual clinicalconsiderations for problematic patients nor tostifle progress. It is also not meant to be alegal formulation from which variations definemedical malpractice. The Society understandsthat in some clinics the method of treatmentderives from national standards while inothers access to medical equipment andsupplies is limited, and therefore the suggestedtreatments are impractical. Adaptability andinclusiveness does come at the price thatmembers can rightly be critical of what theysee as vagueness or imprecision in definitions,qualifiers in the choice of words (e.g., the useof “may... perhaps... unclear”, etc.) andmention (albeit without endorsement) oftreatment options supported by limited harddata. Most members are frustrated by thereality that NO treatment method has reallyundergone a satisfactory meta-analysis(let alone rigorous, randomized, stratified,long-term, controlled study). With this understanding,the absence of definitive answersand optimally conducted clinical trials, andwith emerging technologies and newapproaches and discoveries on the horizon,some degree of uncertainty, ambiguity, andflexibility along with dissatisfaction withcurrent lymphedema evaluation and managementis appropriate and to be expected.We continue to struggle to keep the documentconcise while balancing the need for depthand details. With these considerations inmind, we believe that this latest versionpresents a Consensus that embraces the entireISL membership, rises above national standards, identifies and stimulates promisingareas for future research and represents the best judgment of the ISL membership on  how to approach patients with peripheral lymphedema as of 2013. Therefore the document has been, and should continue to be, challenged and debated in the pages of Lymphology (e.g., as Letters to the Editor), and ideally will remain a continued focal point for robust discussion at local, national and international conferences in lymphology and related disciplines. We further anticipate as experience evolves and new ideas and technologies emerge that this “living document” will undergo further periodic revision and refinement as the practiceand theories of medicine and specificallylymphology change and advance

ISL NEWS

ISL New

ISL News

ISL New

ISL News

New